33 results
8-K
EX-10.1
IMUX
Immunic Inc
20 Oct 20
EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
7:19am
of environmental and social risks, including human rights violations, linked to the projects it finances and has therefore established its transparency policy … Cooperation and Development and the Global Forum on Transparency and Exchange of Information for Tax Purposes and any successor organisations.
"List
8-K
EX-10.2
IMUX
Immunic Inc
20 Oct 20
EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
7:19am
progress reports/ Global Forum rating (http://www.oecd.org/tax/transparency/GFratings.pdf; http://www.oecd.org/tax/transparency/exchange-of-information
8-K
gmmv 0jb4g
17 Jul 19
Updated Unaudited Pro Forma Condensed Combined Financial Information
5:15pm
424B3
33dc8a94te6uspdt
19 Feb 19
Prospectus supplement
5:03pm
S-4/A
nydtbosxyq4902
14 Feb 19
Registration of securities issued in business combination transactions (amended)
9:02am
S-4
ui1hod0dqbtv009wala
4 Feb 19
Registration of securities issued in business combination transactions
5:58pm